
Place your order, and our doctor can provide a free prescription. Already have one? Simply upload it and we'll process your order.
Add to cart
Complete Checkout
Get a FREE Teleconsultation & Receive Your Order
• Active ingredient: Tirzepatide 5 mg per weekly dose.
• Pack size: 1 Mounjaro KwikPen containing 4 once-weekly doses.
• Inject once weekly on the same day each week, with or without food.
• Inject into the abdomen, thigh or upper arm, using a different injection site each week.
• Use a new needle for every injection.
• Store refrigerated at 2°C–8°C before first use. Once opened, the KwikPen may be stored below 30°C for up to 30 days. Do not freeze.
• Discard the KwikPen after all 4 doses have been used.


Connect with an expertMounjaro 5mg is a prescription strength of tirzepatide. Tirzepatide acts on GIP and GLP-1 receptors involved in metabolic and blood glucose regulation.
Mounjaro 5 mg is included among the strengths listed in Lilly's Gulf product information, which covers Kuwait. Local availability may vary, so it should be confirmed with an appropriate healthcare provider or pharmacy.
Mounjaro is generally administered once weekly according to the prescribing instructions provided by your healthcare professional.
The appropriate dose depends on the prescribed treatment plan. Do not begin at 5mg or change to this strength unless your healthcare professional has instructed you to do so.
Commonly reported side effects can include nausea, diarrhoea, reduced appetite, vomiting, constipation, indigestion and abdominal discomfort.
Tirzepatide can influence appetite and body weight, but whether it is appropriate for weight management depends on the individual patient, local approved indications and medical assessment.
No. Dose adjustments should only be made by your prescribing healthcare professional based on your treatment response and tolerability.
The main difference is the amount of tirzepatide delivered. Mounjaro is available in several strengths, and your healthcare professional determines which dose is appropriate for your treatment stage.
Mounjaro 5mg KwikPen for Weight Management
Mounjaro 5mg KwikPen contains tirzepatide and is administered once weekly. It may support appetite control and weight management for appropriate patients when prescribed as part of a medically supervised treatment plan. Individual results may vary.
Mounjaro 5mg is one of the available strengths of tirzepatide. Tirzepatide acts on both GIP and GLP-1 receptors, which are involved in metabolic regulation, insulin response and appetite.
Mounjaro is administered as a prescription injection according to a treatment plan set by a healthcare professional. The appropriate strength can vary from person to person depending on medical history, previous treatment, response and tolerability.
People researching Mounjaro Kuwait 5mg should not select or change their dose based on online experiences. Medical supervision is important because treatment response and side effects can differ significantly between individuals.
Mounjaro 5mg should be used only as prescribed, with regular follow-up to assess how well the treatment is working and whether any adjustments are appropriate.